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Edited by Hans-Dieter KlenkAbstract Hydroxymandelate synthase (HmaS) and hydroxy-
phenylpyruvate dioxygenase (HppD) are non-heme iron-depen-
dent dioxygenases, which share a common substrate and ﬁrst
catalytic step. The catalytic pathways then diverge to yield
hydroxymandelate for secondary metabolism, or homogentisate
in tyrosine catabolism. To probe the diﬀerences between these
related active sites that channel a common intermediate down
alternative pathways, we attempted to interconvert their activi-
ties by directed evolution. HmaS activity was readily introduced
to HppD by just two amino acid changes. A parallel attempt to
engineer HppD activity in HmaS was unsuccessful, suggesting
that homogentisate synthesis places greater chemical and steric
demands on the active site.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Hydroxyphenylpyruvate dioxygenase (HppD) catalyses the
ﬁrst dedicated step of tyrosine catabolism, the oxidation of
4-hydroxyphenylpyruvate (HPP) to homogentisate (HGA),
with incorporation of both atoms of molecular oxygen into
the product and release of CO2 (Fig. 1) [1]. This enzyme has
been a subject of research over several decades, as mutations
cause type III tyrosinaemia, an inherited disorder of tyrosine
metabolism, and because homogentisate is a precursor of plas-
toquinone and tocopherols in plants. Inhibitors of HppD areAbbreviations: HppD, 4-hydroxyphenylpyruvate dioxygenase; HppD_
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HppD_PF, 4-hydroxyphenylpyruvate dioxygenase Pseudomonas ﬂuo-
rescens; HmaS, 4-hydroxymandelate synthase; HPP, 4-hydroxyphe-
nylpyruvate; HGA, homogentisic acid; HMA, 4-hydroxymandelic acid
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doi:10.1016/j.febslet.2006.05.018clinically and commercially important for treatment of tyrosi-
naemias [2] and as herbicides [3].
The closest homologue to HppD, hydroxymandelic acid syn-
thase (HmaS), is involved in the production of glycopeptide
antibiotics in Amycolatopsis orientalis [4,5] and at least eight
other homologues have since been found in microbes with clin-
ically important secondary metabolites. Unusual non-protein-
ogenic amino acids are incorporated into non-ribosomal
peptides, where they contribute to the impressive chemical
and structural diversity of this family of natural products [6].
HmaS catalyses the ﬁrst biosynthetic step of one such amino
acid, 4-hydroxyphenylglycine, by reaction of molecular oxygen
with HPP to yield 4-hydroxymandelic acid (HMA) (Fig. 1).
HppD and HmaS share high homology (20–35% amino acid
identity), the same substrate and the same initial catalytic step.
This presents a unique opportunity to study how a common
reaction intermediate is partitioned along divergent pathways
by closely related active sites.
In the crystal structure of HppD from Pseudomonas ﬂuores-
cens the catalytic FeII is coordinated by two histidines and a
glutamate [7]. A hydrophobic substrate binding pocket is ob-
served, but the orientation of substrate binding is unknown.
Recently the structures of HppDs from four other organisms
have become available: Zea mays, Arabidopsis thaliana, Strep-
tomyces avermitilis and Rattus norvegicus [8–10]. The struc-
tures of Arabidopsis thaliana and S. avermitilis HppD
contain inhibitors in the hydrophobic cavity, which are coordi-
nated to FeII. Using these structural data, and the increasing
number of sequenced homologues, the aim of this study was
to uncover the crucial diﬀerences between HmaS and HppD
active sites by interconverting their activities. Since none of
the crystal structures contain substrate or products, and there
is currently no structure of any HmaS, a high throughput ap-
proach was chosen for the best chance of identifying mutants
with interconverted activities.2. Materials and methods
2.1. Plasmids
The cloning of HmaS and HmaO from the antibiotic producer Amy-
colatopsis orientalis has already been described [4,15]. 4-Hydroxyphe-
nylpyruvate dioxygenase P. ﬂuorescens (HppD_PF) was ampliﬁed by
PCR from P. ﬂuorescens DNA, DSMZ strain 4358, and ligated in
pET28a+. HppD_PF has 14 amino acid diﬀerences from the protein
crystallised by Serre and coworkers [7]. The sequence has been depos-
ited (accession number DQ364627). 4-Hydroxyphenylpyruvate dioxy-
genase S. avermitilis (HppD_SA) (accession number U11864) and
HGD, a putative 1,2 homogentisate dioxygenase (accession numberblished by Elsevier B.V. All rights reserved.
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Fig. 2. High-throughput screen for HppD and HmaS activities in
E. coli. Absorption spectra of the supernatants from E. coli expressing
HmaS (squares), HppD (circles) or no recombinant protein (triangles).
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Fig. 1. Reactions of HmaS and HppD. HmaS catalyses the oxidation
of 4-hydroxyphenylpyruvate (1) to (S)-4-hydroxymandelate (2),
whereas HppD catalyses the oxidation of the same substrate to
homogentisate (3).
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genomic DNA and cloned in pET28a+. Primer sequences are available
as supporting information.
Libraries were prepared by PCR, using oligonucleotides to encode
diversiﬁed regions; a list of primers is available in the supporting infor-
mation. Libraries were prepared in strain DH10B, the number of col-
onies was noted, then cells were scraped up to purify plasmid DNA.
Libraries containing mutations at residue 335 plus one or both of
214 and 216 were prepared sequentially: residue 335 was diversiﬁed
ﬁrst, and this library was used as a template for PCR to introduce
diversity at the other residue(s). Library quality was checked by
sequencing four individual members from each library. Over 96% of
library members contained full length genes with the expected diversi-
ﬁed residues. The frequency of PCR-induced mutations was less than
one per 4 kb.
2.2. Library screening in microplates
Libraries were transformed in Escherichia coli BL21-CodonPlus-RP
(Stratagene). Cultures were grown in 1 ml LB-tyrosine in Deepwell
microplates (Fisher). LB-tyrosine was prepared from LB (1 litre) by
the addition of 1 g tyrosine, dissolved in 20 ml 1 M HCl, followed by
100 ml 1 M disodium orthophosphate and 2 ml 30 mg/ml kanamycin
sulphate. After 48 h growth at 30 C, cells were harvested by centrifuga-
tion and 100 ll of the supernatant was transferred to a UV-transparent
microplate (Grenier). The absorbance was measured at 280–440 nm,
10 nm intervals, using a Strectramax Plus spectrophotometer running
Softmax Pro (Molecular Biosciences).
The phenotypes of the clones were classiﬁed as HmaS wild type-like
(A330 > 2.0, A430 < 0.1, no visible pigmentation), HMA producer
(A330 > 0.3, A430 < 0.1, no pigmentation), HppD wild type-like
(A330 > 2.0, A430 > 0.1, dark pigmentation), HGA producer (A330 >
0.3, A430 > 0.1, brown pigmentation), or inactive (A330 < 0.3). Plasmids
encoding genes of interest were prepared from the cell pellets by stan-
dard methods. To sample the range of amino substitutions that are
tolerated by the enzymes, the genes of six wild type-like clones from each
single-residue library were sequenced. Only one gene contained a PCR-
induced mutation outside the active site: HmaS H106R T214V.
2.3. Overexpression and puriﬁcation
All proteins were expressed in E. coli BL21-CodonPlus-RP. The
standard procedure was growth at 30 C to mid-log phase followed
by the addition of IPTG to 0.1 mM then 3 h expression. For HmaO,
cells were grown at 37 C to mid-log then grown at 40 C for 6 h. Cells
were lysed using lysozyme in phosphate buﬀer (100 mM sodium phos-
phate pH 8.0, 150 mM NaCl, 10 mM imidazole, 1 mg/ml lysozyme
with Benzonase (Novagen)). Proteins were puriﬁed using nickel resin
by standard methods, the concentration measured by the Bradford as-
say and the purity estimated by PAGE. Proteins were transferred to
50 mM sodium phosphate pH 7.5 for assay.
2.4. Measuring HMA and HGA production by coupled assay
HMA production was assayed spectrophotometrically by coupling
to hydroxymandelate oxidase and measuring the absorbance of 4-
hydroxybenzaldehyde at 330 nm. Reactions contained 20 nM–20 lM
test protein and 2 lM hydroxymandelate oxidase in sodium phosphate
buﬀer (50 mM, pH 8.0) plus 50 lM FeII, 0.5 mM ascorbic acid,
0.1 mg ml1 catalase. Reactions were started by the addition of1 mM HPP from a stock solution of 100 mM HPP in 500 mM sodium
phosphate pH 8.0, and incubated at 37 C. Reactions were determined
to be tightly coupled as the rates were unchanged by increasing concen-
trations of hydroxymandelate oxidase. Rates quoted in Table 3 are
mean values (standard error <10%) determined within the ﬁrst 90 s.
The extinction coeﬃcient of 4-hydroxybenzoylformate was measured
as 11700 m1 cm1.
HGA production was measured under the same conditions but using
homogentisate dioxygenase as the coupling enzyme and measuring the
absorption of 4-maleyl-acetoacetate at 318 nm (extinction coeﬃcient
13500 M1 cm1).3. Results
3.1. High-throughput activity assays
A microplate screen was developed to assay HppD and
HmaS activities. Since E. coli lack a catabolic pathway for
tyrosine, there is no endogenous production or degradation
of HGA [11]. Expression of HppD in E. coli leads to the accu-
mulation of HGA in the culture medium, where the spontane-
ous oxidation and polymerisation of HGA into ochronotic
pigment provides a convenient assay [12]. Two HppDs were
studied: HppD_PF from P. ﬂuorescens and HppD_SA from
S. avermitilis. Both are well expressed in E. coli, and the con-
centration of HGA in the culture supernatant reaches 0.3 g/l,
whereas the detection limit for HGA is approximately
10 mg/l.
HmaS activity cannot be monitored by direct spectropho-
tometric assay because the absorption maxima of HPP and
HMA are too similar. In cultures of E. coli, however, we ob-
served slow conversion of HMA to 4-hydroxybenzaldehyde,
absorption maxima at 270 and 330 nm. HMA is not an or-
dinary metabolite of E. coli, so it is likely that this conversion
is catalysed by an oxidase with promiscuous substrate speci-
ﬁcity. The product concentration in cultures overexpressing
HmaS was estimated as 0.3 g l1, with a detection limit of
approximately 10 mg l1. Simple analysis of culture superna-
tants thus enables detection of HmaS and HppD activities
(Fig. 2).
3.2. Identiﬁcation of crucial residues for HmaS activity
Initially ﬁve HmaS residues were chosen for mutagenesis:
M199, T214, I216, I335 and Y339. These amino acids are con-
served amongst all nine hydroxymandelate synthases, whereas
alternative amino acids, L, P, N, F and F, are conserved in the
corresponding positions in the HppD family. Furthermore, the
analogous residues in HppD make up part of the active site
cavity in the crystal structure of HppD_PF, and L199, P214,
Fig. 4. Frequency of active enzymes in libraries diversiﬁed at a single
residue. Solid bars show the frequency of enzymes with wild type-like
activity, hashed bars represent enzymes with lower levels of activity.
SA is HppD_SA and PF is HppD_PF.
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itor NTBC in the crystal structure of HppD_SA : 5.3 A˚, 3.7 A˚,
4.3 A˚ and 3.5 A˚, respectively (Fig. 3, residues numbered
according to HmaS) [9].
Five libraries of genes, were constructed, each with satura-
tion mutagenesis at a single codon. Ninety-six clones were
examined from each library (P > 0.95 that a given codon was
sampled) and their activity classiﬁed as HmaS wild type,
HMA producer or inactive. The frequencies of active enzymes
occurring in each library are shown in Fig. 4. Despite the com-
plete conservation of these residues within the HmaS enzyme
class, all positions were tolerant to mutation. In particular,
60% of enzymes mutated at M199 and 39% mutated at Y339
have wild type-like activity and only 18% and 52% are com-
pletely inactive. In light of their high tolerance to mutation,
these two residues were not considered important for enzyme
activity, and were not investigated further. T214, I216 and
I335 are less tolerant to mutation, although a subset of amino
acid substitutions have no eﬀect on the ﬁnal yield of HMA. To
sample the range of these substitutions, six wild-type like mu-
tants were sequenced from each library. Valine and aspartate
were seen at position 214, leucine, aspartate, alanine and serine
at position 216, and asparagine, valine, leucine, threonine and
proline at position 335. These three positions (214, 216 and
335) were chosen for further investigation by combinatorial
mutagenesis and by mutation of the corresponding residues
in HppD.
3.3. Identiﬁcation of critical residues for HppD activity
Libraries were constructed from HppD_SA and HppD_PF
with saturation mutagenesis of P214, N216 and F335 singly
and in pairs. Libraries were screened as for HmaS, revealing
these HppDs to be much less tolerant to mutation than HmaS
(Fig. 4). In HppD_SA library 214 and library 216 the fre-Fig. 3. Structure of Streptomyces avermitiliquency of clones with wild type-like activity is the same as
the predicted frequency of wild type genes, suggesting that
any amino acid substitution at these three positions disrupts
enzyme function. Sequencing the clones with wild type-like
activity conﬁrmed that these clones contain proline at position
214 and asparagine at 216, whilst position 335 can tolerate
hydrophobic substitutions (valine, leucine and methionine)
without aﬀecting HGA yield. Libraries of HppD_PF con-
tained a higher frequency of clones with wild-type activity than
the corresponding HppD_SA libraries. Six wild type-like mu-
tants were from each single-residue library were sequenced,
revealing a variety of substitutions: leucine and alanine at po-
sition 214 glutamine, methionine and valine at position 216,
and leucine and valine at position 335.
3.4. Screening double HppD mutants for HMA production
No HMA producing enzymes were found amongst the sin-
gle HppD mutants, but enzymes with this switched speciﬁcitys HppD with bound inhibitor NTBC.
Table 1
Frequency of HGA active mutants in HppD libraries with two
randomised residues
Library HppD_SA HppD_PF
WT HG HM WT HG HM
214 + 216 0.3 0.5 0.3 – – –
214 + 335 0a 10 2 4 9 3
216 + 335 0a 0.3 2 0.8 2 9
WT represents the percentage of library members with wild type levels
of HGA.
HG the percentage with detectable HGA.
HM the percentage with detectable HMA.
aNo wild type-like enzymes were found amongst 384 variants screened.
Table 3
Rates of reaction of wild type and mutant enzymes
Enzyme Mutations HGA production
min1
HMA production
min1
HmaS Wild type <0.02 7200
HppD_SA Wild type 560 <0.02
HppD_PF Wild type 232 <0.02
SA1 N216F, F335V 0.088 0.404
SA2 N216L, F335V 0.126 0.302
SA8 P214T, N216P 0.187 0.364
PF1 N216G, F335V <0.02 0.047
Initial reaction rates were measured at 1 mM HPP.
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Fig. 5. HMA production by mutant SA1. Measurements taken at
1 mM HPP, with enzyme concentrations of 20 lM (circles), 10 lM
(triangles) or 5 lM (squares). Substrate inhibition causes the diﬀerence
between initial and steady state rates.
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tants. From a screen of 1488 HppD mutants, 61 HMA-pro-
ducing enzymes were identiﬁed. Indeed, some libraries
contain a higher frequency of ‘‘reversed’’ HMA-producers
than ‘‘wild type’’ HGA-producers (Table 1). A number of
these double mutants with altered speciﬁcity were isolated
for further study.
3.5. Screening double and triple HmaS mutants for HGA
production
Analogous libraries of HmaS with mutations of pairs, or all
three residues 214, 216 and 335 were constructed and screened.
The frequency of active enzymes was high: 41% of clones in li-
brary 214 + 216 (12% had wild type-like yields), 20% of library
214 + 335 (10% wild type yield), 28% of library 216 + 335 (14%
wild type yield) and 15% of triple mutants (6% wild type yield).
No HGA-producing enzymes were detected amongst 1632
mutants screened.
3.6. Characterisation of selected clones
Sixteen HMA-producing HppD mutants were sequenced:
HppD_SA variants SA1-9 and HppD_PF variants PF1-7
(Table 2). Wild type enzymes and four mutants were puriﬁed
for in vitro assays. The rates of reaction were determinedTable 2
Sequences of HMA-producing HppD mutants
Enzyme Residue
214 216 335
HppD P N F
HmaS T I I
SA1 F V
SA2 L V
SA3 F A
SA4 F V
SA5 F V
SA6 F I
SA7 L V
SA8 T P
SA9 F G
PF1 G V
PF2 S V
PF3 V V
PF4 Q I
PF5 A V
PF6 V T
PF7 L A
Blank cells indicate that the residues were not mutated.by spectrophotometric coupled assays: HMA was detected
by enzymatic conversion to 4-hydroxybenzoylformate by
hydroxymandelate oxidase, and HGA was detected by con-
version to 4-maleyl-acetoacetate using homogentisate dioxy-
genase (Table 3 and Fig. 5). The in vitro activity assay
conﬁrmed that the wild type enzymes are extremely speciﬁc
in terms of product formation, whilst demonstrating that
all four mutant HppDs display HmaS activity together with
a lower level of residual HppD activity.4. Discussion
HppD and HmaS exhibit impressive product speciﬁcity,
each channelling the reactive intermediate down a single reac-
tion pathway with at least 99.9% accuracy. In assays capable
of detecting product formation at 0.02 min1 (2 · 104-fold
lower than the kcat of HppD_SA), no side products of either
enzyme could be detected. Nevertheless, if mutations are intro-
duced to the active site of HppD then the product speciﬁcity
may be switched to HMA instead of HGA. HMA product-
speciﬁcity is relatively frequent amongst mutants of both
HppD_SA and HppD_PF, even though HppD_PF has rela-
tively low homology to HmaS (26% amino acid identity, com-
pared to 34% between HppD_SA and HmaS).
Whilst this study was underway the potential of HppD
mutants to catalyse HMA production was demonstrated
H.M. O’Hare et al. / FEBS Letters 580 (2006) 3445–3450 3449independently [13]. Four individual residues of HppD_SA
were converted to their HmaS counterparts, and the products
of these enzymes were analysed by HPLC. Two mutants,
N216I and F335I, were found to yield a mixture of products
which includes HMA, HGA and an unexpected product,
oxepinone. The identiﬁcation of oxepinone is particularly
interesting, as it supports the involvement of a benzene oxide
intermediate in the reaction and allowed a mechanism to be
proposed [13].
Our choice of a high throughput approach allowed us to use
saturation mutagenesis to eﬀect a greater change in HppD
product speciﬁcity than that achieved previously. The micro-
plate assay is a sensitive method for detecting HGA or
HMA alone, but is less sensitive for detecting the minor com-
ponent of a mixture of the two molecules. For this reason, all
of the HMA-producing mutants identiﬁed in this study are
thought to make HMA as the major product, as conﬁrmed
by in vitro assay of four such enzymes. The HppD_SA mu-
tants studied by Gunsior et al. were also encoded in the li-
braries used in this study, but they were not identiﬁed as
HMA-producers during screening because they produce a
greater concentration of HGA than HMA.
The interconversion of enzyme activities was attempted in
both directions. In the course of screening HmaS mutants we
observed a remarkable tolerance of this enzyme to mutation.
Since the screen was an end-point assay, the product distribu-
tion reﬂects enzyme accuracy rather than eﬃciency. Surpris-
ingly many HmaS mutants with substitutions at three active
site residues have no reduction in HMA yield. HppD_SA, by
comparison, is extremely intolerant to mutations at the analo-
gous residues: any substitution at position 214 or 216, and
most substitutions at 335, reduce or abolish the production
of HGA. HppD_PF showed greater active site plasticity than
HppD_SA, though it is not clear whether the diﬀerence be-
tween the enzymes reﬂects a general diﬀerence between gram
negative and gram positive eubacterial HppDs or a diﬀerence
between the particular proteins.
The diﬀerent responses of HmaS and HppD to mutagenesis,
and the failure to engineer HGA production in HmaS, suggest
that HGA production requires an active site with a much more
precise conﬁguration than HMA production. The ﬁrst step of
catalysis is thought to be the same for HmaS and HppD [4,15]
(Fig. 1), and this is supported by the discovery of HppD mu-
tants that synthesise HMA (in this study and [13]). The more
stringent active site requirements of HppD therefore reﬂect a
greater level of steric control needed in the later step(s) of
catalysis. Over 60 HppD mutants with changed product spec-
iﬁcity were identiﬁed, and the mutations are not restricted to
the substitution of corresponding residues from HmaS. Rather
than mimicking the active site of HmaS, these mutations may
block HGA formation and allow HMA to be formed as a
default or side product.
Residues 214, 216 and 335 line the active site cavity of
HppDs (Fig. 2). Considering the range of mutations that give
rise to HMA-producing mutants (Table 3), it is clear that most
substitutions preserve the hydrophobic character of the cavity,
whilst perturbing the shape by the addition of one or more
bulky side chains. It seems likely that similar mutations at
other positions in the HppD active site, or in HppDs from
other organisms, might also give rise to HMA-producing en-
zymes. It is interesting to note that some amino acid substitu-
tions, such as N216V and F335V in HppD_PF, do not aﬀectproduct speciﬁcity when they occur singly, but cause reversal
of product speciﬁcity when they occur in combination, under-
lining the utility of a combinatorial approach to enzyme
engineering.
The kinetics of HppD_SA have been examined in detail and
it is known that this enzyme is aﬀected by substrate inhibition
[14]. Our measurements of HGA production by wild type
HppD_SA were close to those previously published (kcat of
7.7 s1 compared to 7 s1), and we also noted that the wild
type HppDs and HppD mutants suﬀer from substrate inhibi-
tion at substrate concentrations of 1 mM or greater (Km
27 lM). This same inhibition is observed for HppD mutants,
whether HMA or HGA production is monitored, yet HmaS
itself has standard Michaelis Menten kinetics, kcat = 40 s
1,
Km = 149 lM and does not display substrate inhibition (Cho-
roba, unpublished).
Finally, the evolution of glycopeptide antibiotic gene clus-
ters poses a diﬃcult question: certain sugar and amino acid
building blocks do not play a role in primary metabolism
and their biosynthesis is encoded within the cluster. Since the
biosynthetic intermediates (such as HMA) have no known
function apart from further processing and incorporation into
the ﬁnal antibiotic product, it is hard to explain how these
pathways might have evolved. The evolution of new protein
functions has been proposed to arise by improvements in pro-
miscuous enzyme activities [16]. Given their high homology, it
is extremely likely that HmaS evolved from a HppD, but
HppD has no detectable HmaS activity. Furthermore, HMA
requires two further transformations to yield the functional
building block 4-hydroxyphenylglycine. This study demon-
strates the surprising ease with which the pathway might have
evolved: two amino acid changes are suﬃcient for conversion
of HppD into an HmaS, and a pre-existing promiscuous en-
zyme activity in E. coli catalyses further transformation, lead-
ing to the accumulation of millimolar concentrations of 4-
hydroxybenzoylformate and reconstituting two of the three
steps of 4-hydroxyphenylglycine biosynthesis.
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